Biggie Smalls CBD
Original price was: $500.$350Current price is: $350.
Biggie Smalls CBD is an indica-dominant therapeutic hemp cultivar bred from broadleaf Kush selections, specifically isolated for its high density of compact “small buds” (popcorn calyxes) saturated in non-intoxicating glandular trichomes. Grown under certified GACP agricultural protocols and packaged within EU-GMP cleanrooms, it delivers an aromatic profile of ripe summer berries, damp forest earth, sweet musk, and subtle spiced fuel. Formulated for daytime tension relief and mild evening sedation with zero psychotropic impact, every lot provides verified cannabinoid homogeneity backed by ISO/IEC 17025 accredited pharmacopoeial testing
Biggie Smalls CBD traces its heritage to stabilized European hemp chemotypes backcrossed with legacy broadleaf indica stock. Selected primarily for its ability to produce tight, resinous lower and mid-canopy “small buds” without sacrificing secondary metabolite accumulation, this cultivar yields high calyx-to-leaf ratios and an abundant distribution of capitate-stalked glandular trichomes.
Cultivated indoors and in high-tech hybrid glasshouses in accordance with GACP standards, cultivation parameters—such as automated nutrient fertigation, relative humidity, and air filtration—are monitored to eliminate heavy metal uptake and prevent botrytis or powdery mildew. In European clinical and pharmacy distribution—notably in Germany, Austria, France, and the UK—Biggie Smalls CBD is utilized as an inhalation formulation for patients managing daytime anxiety, generalized musculoskeletal discomfort, stress-induced migraines, and sleep-onset restlessness without cognitive impairment.
Technical Specifications & Certificate of Analysis (CoA)
| Specification | Standard / Analytical Value |
| Cultivar Lineage | Stabilized Broadleaf Indica × Certified EU Hemp Chemotype |
| Botanical Classification | Indica-dominant Hybrid (~70/30) |
| Flower Grading | Small Buds / Mini-Calyx Selection (10 mm – 22 mm diameter) |
| Total CBD Potency | 12.0% – 16.0% w/w (CBD + 0.877 × CBDA) |
| Total THC Potency | < 0.20% – 0.30% w/w (Fully compliant with EU Regulation 2021/2115) |
| Minor Cannabinoids | CBG (0.6% – 1.4%), CBC (0.3% – 0.8%), CBDV (0.2% – 0.5%), CBN (< 0.05%) |
| Primary Terpenes | Beta-Myrcene, Beta-Caryophyllene, Alpha-Pinene, Alpha-Bisabolol |
| Total Terpene Content | 1.8% – 3.2% dry weight |
| Moisture Content | 8.0% – 11.5% (Ph. Eur. 2.2.32) |
| Treatment / Decontamination | Beta-Irradiated / E-Beam / Non-Irradiated lots available |
| Cultivation Standard | GACP (Good Agricultural and Collection Practice) |
| Manufacturing Standard | EU-GMP (Good Manufacturing Practice Part I & II) |
| Pharmacopoeial Monograph | European Pharmacopoeia (Ph. Eur.) Monograph 3028 |
Sensory & Terpene Profile Breakdown
-
Ripe Forest Berries & Sweet Musk: Heavy concentrations of Beta-Myrcene produce an upfront bouquet of macerated wild blackberries, candied plums, and earthy musk upon grinding.
-
Warm Spiced Earth & Cracked Pepper: Beta-Caryophyllene provides an earthy undertone accented by cracked black peppercorn, warm clove, and weathered cedarwood.
-
Soothing Chamomile & Floral Linens: Alpha-Bisabolol introduces a calming, sweet herbal tea and wildflower note that softens the vapor profile during thermal vaporization.
-
Subtle Diesel Snap: Trace volatile sulfur compounds contribute a faint, clean fuel aroma on the finish, inherited from its Kush ancestral background.
-
Visual Morphology: Compact, tightly manicured, nugget-sized olive-green buds featuring subtle copper-red pistils and a dense, frosted glaze of mature glandular trichomes.
European Compliance, Quality Assurance & Distribution
-
EU-GMP Quality Assurance: Cured, manicured, and packaged in certified pharmaceutical cleanroom environments under EU-GMP parameters, ensuring lot-to-lot homogeneity, physical purity, and zero foreign matter.
-
Non-Narcotic Regulatory Clearance: Derived exclusively from industrial hemp varieties registered in the EU Common Catalogue of Plant Species and verified to contain total THC concentrations below statutory limits (< 0.2% / < 0.3% w/w). Classified as a non-narcotic agricultural product eligible for cross-border commercial transport across EU/EEA member states.
-
Accredited Laboratory Testing: Fully analyzed by independent ISO/IEC 17025 accredited analytical laboratories in strict compliance with Ph. Eur. Chapter 5.1.8, certifying the absence of heavy metals (lead, arsenic, cadmium, mercury), residual agrochemicals, aflatoxins, and microbial pathogens.
-
Schengen Cross-Border Logistics: Supported by an end-to-end regulatory compliance pack, including batch-specific Certificates of Analysis (CoAs), active pharmaceutical ingredient (API) declarations, technical data sheets (TDS), and commercial intra-EU transport manifests.
-
Medical Packaging Integrity: Sealed in light-blocking, food- and pharma-grade foil pouches or airtight medical glass containers under nitrogen flushing, equipped with integrated 62% relative humidity control sachets to preserve volatile monoterpenes and maintain optimal calyx sponginess during transit and shelf life.
Product Tags
Related products
SWEETZ EXOTICS
$1,750
MOCHI GAS
$1,025
BLUE LOBSTER
$975
BLUE WAGYU
$925
